Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FE598
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,149
Award facts
- Contract value 100% obligated
- $14,148.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $14,148.63 to AmerisourceBergen Drug Corp on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded contract, utilizing no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and falls under the company's pharmaceutical prime vendor program supporting federal medical procurement needs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates its capability to fulfill federal medical supply requirements through open competition, with delivery orders consistently structured as firm fixed-price arrangements. This particular delivery order contributes to the broader DLA Pharmaceutical Prime Vendor Global Program, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles designed to ensure reliable pharmaceutical supply chains for federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DU26FE598?
SPE2DU26FE598 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DU26FE598 worth?
The government has obligated $14,149 on SPE2DU26FE598.
Is contract SPE2DU26FE598 an order under another contract?
Yes. SPE2DU26FE598 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE598 competed?
The extent of competition for SPE2DU26FE598 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award